Tempest Therapeutics, Inc.·4

Jan 5, 8:02 PM ET

Whiting Samuel 4

4 · Tempest Therapeutics, Inc. · Filed Jan 5, 2023

Insider Transaction Report

Form 4
Period: 2023-01-03
Whiting Samuel
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-01-03+69,70069,700 total
    Exercise: $1.23Exp: 2033-01-02Common Stock (69,700 underlying)
Footnotes (1)
  • [F1]These stock options vest in a series of 48 equal monthly installments measured from January 3, 2023, subject to the reporting person's continued service.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION